NovoCure Ltd — Director's Dealing 2019

Feb 14, 2019

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NovoCure Ltd (NVCR)
CIK: 0001645113
Period of Report: 2019-02-12

Reporting Person: Danziger Asaf (Director, Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2019-02-12	Ordinary Shares	M	32098	$11.46	Acquired	203262	Direct
2019-02-12	Ordinary Shares	S	32098	$51.46	Disposed	171164	Direct
2019-02-13	Ordinary Shares	M	17902	$11.46	Acquired	189066	Direct
2019-02-13	Ordinary Shares	S	17902	$51.46	Disposed	171164	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2019-02-12	Options to Buy Ordinary Shares	$11.46	M	32098	Disposed	2026-02-24	Ordinary Shares (32098)	Direct
2019-02-13	Options to Buy Ordinary Shares	$11.46	M	17902	Disposed	2026-02-24	Ordinary Shares (17902)	Direct

Footnotes

F1: Transaction was made pursuant to a Rule 10b5-1 trading plan adopted by Mr. Danziger.

F2: Fully vested and currently exercisable as of the date hereof.